EsoBiotec

Belgium
Mont-Saint-Guibert, Wallonia, Belgium, 1435

Company profile

EsoBiotec company profile

EsoBiotec is a Belgian biotechnology business focused on the discovery of novel cancer therapies.EsoBiotec's objective is to enable the human body to fight cancer by delivering 'in vivo' cell engineering to patients.

Business identity

Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2020-01-01, Year

Headquarters

Postal code
1435
Country code
BE
Continent
Europe

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
3
Total equity funding
$5.6M
Last funding
Series A / $2.2M / 2023-12-12
Last equity funding
Series A / $2.2M
Investors
6
Lead investors
3
Founders
1
Articles
44
Exited on
2025-03-17

Founders and investors

Founders

Jean-Pierre Latere

Lead investors

Thuja CapitalUCB VenturesWalloon

Investors

Invivo Capital PartnersSambrinvestS.R.I.W.Thuja CapitalUCB Ventures